Health care provider perspective on the burden and awareness of Hepatitis B and C in Kafanchan, Kaduna state Nigeria.


  • Johnson Ogwuche Ogira Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bingham University, Karu Nasarawa State Nigeria
  • Ruth Onyema Odoh Department of Political science, University of Jos, Plateau State Nigeria.
  • Ise Uduak Peter 3Department of Pharmacology and Toxicology, Faculty of Pharmacy, Bingham University, Karu Nasarawa State Nigeria.
  • Victor Olusegun Awoniyi Pharmaceutical Association of Nigerian Students, Bingham University, Karu Nasarawa State Nigeria.
  • Moses Attahghen Akuki College of strategic learning and health Technology Kauchikau, Karu Nasarawa State Nigeria.


Hepatotropic Viruses, Hepatitis Awareness, Hepatitis B and C


Background: Viruses that target the liver primarily are described as hepatotropic viruses, with each of them causing clinically  signifificant hepatitis and in some cases to the development of chronic viral hepatitis with viral persistence. Six human viruses have  been identifified, including hepatitis AB C and D (HDV), with the potential to cause acute inflflammation of the liver, resulting in acute  hepatitis carcinoma. This study determined the healthcare provider's view of awareness of hepatitis B and C in Kafanchan, Kaduna  state, Nigeria with emphases on hepatis B due to its prevalence. 

Result: Majority of respondents who fifilled the questioner was 30 years, representing 46.0 %, 65.0 % of respondents were male, while  35.0 % were females. Seventy-eight percent (116) of respondents reported that Hepatitis C and Hepatitis B awareness was not enough  while 13 % (20) indicated that the awareness is enough. Majority of the respondents (97.01 %) said a cure exists for HCVand HBV, while 19.5 % said there was no cure.  

Conclusion This survey conducted among healthcare providers, reveals the level of awareness of HBVand HCVinfection in Kafanchan  Kaduna state and from the above data, it is clear that the level of awareness is not enough therefore, more awareness strategy be put  in place for effffective information.   

Author Biography

Johnson Ogwuche Ogira, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bingham University, Karu Nasarawa State Nigeria




WH.O., (2021). Hepatitis B key. facts. etail/hepatitis-b. Accessed 29 Sept 2021.

Global Burden of Disease Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause- specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2013;385(9963):117–71.

Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2010 (GBD 2010) results by cause 1990–2010. Institute for Health Metrics and Evaluation ( IHME ) . data/gbd-2010-results-cause-1990-2010. Accessed 5 Feb 2021.

WH.O., (2016). Global health sector strategy on viralhepatitis , 2016–2021 . 246177/WHO - HIV - 2016.06eng.pdf?sequence=1. Accessed 27 Jan 2021.

WHO., (2014). Hepatitis. Sixty-seventh world health assembly. Agenda item 12.3. May 24, 67/a67_r6-en.pdf?ua=1. Accessed 18 Jan 2021.

WH.O., (2019). Hepatitis B fact sheet. etail/hepatitis-b. Accessed 21 Mar 2021.

Indolfi, G., Easterbrook, P., Dusheiko, G., Siberry, G., Chang, MH., Thorne, C., (2019). Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol Hepatol. 4(6):466–76.

Schweitzer, A., Horn, J., Mikolajczyk, RT., Krause, G., Ott, JJ. (2015). Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. The Lancet. 386(10003):1546–55.

Ott, JJ., Horn, J., Krause, G., Mikolajczyk, RT. (2017). Time trends of chronic HBV infection over prior decades—a global analysis. J Hepatol. 66(1):48–54.

Jacobs, B., Mayaud, P., Changalucha, J., Todd, J., Ka-Gina, G., Grosskurth, H. (1997). Sexual transmission of hepatitis B in Mwanza, Tanzania. Sex Transm Dis. 24(3):121–6.

Belo, AC., (2000). Prevalence of hepatitis B virus markers in surgeons in Lagos, Nigeria. East Afr Med J. 77(5):283–5.

Kramvis, A., Kew, MC. (2007). Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res. 37(s1): S9–19.

Chukwuk,a, J.O., Ezechukwu, C.C.. Egbuonu, I. (2019). Cultural influences on hepatitis B Surface Antigen Seropositivity in primary School hildren in Nnewi. Nigeria J., Paediatr. 30(4):140–142.

Luka, S.A., Ibrahim, M.B., Iliya, S. (2018). Seroprevalence of Hepatitis B Surface Antigen among Pr e g n a n t women attending antenatal clinic in Ahmadu Bello University Teaching Hospital Zaria. Nig J Paras. 29:38–41.

Musa, BM., Bussell, S., Borodo,, MM., Samaila AA., Femi OL. (2015). Prevalence of hepatitis B virus infection in Nigeria, 2000–2013: a systematic review and meta-analysis. Niger J Clin Pract. 18(2):163–72.




How to Cite

Ogira, J. O., Odoh, R. O., Peter, I. U., Awoniyi, V. O., & Akuki, M. A. (2023). Health care provider perspective on the burden and awareness of Hepatitis B and C in Kafanchan, Kaduna state Nigeria.: The Nigerian Journal of Pharmacy, 57(1), 532–540. Retrieved from